Howard Steel > Goodwin > New York, United States > Lawyer Profile
Goodwin Offices
THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
- Firm Profile
- Go to...
Howard Steel
Position
Partner
Career
Howard Steel is a partner in Goodwin’s Financial Restructuring practice.
Howard represents debtors, sponsors, purchasers of distressed assets, creditors’ committees, bondholders, lenders, indenture trustees, landlords, and individual secured and unsecured creditors in all aspects of corporate restructuring. He has extensive experience in mass tort cases, SIPA proceedings, distressed M&A, distressed debt trading, financing and intercreditor issues, out-of-court and in-court restructurings, creditors’ rights, fiduciary duties and governance, insolvency related litigation and liquidations and wind-downs.
Education
JD. Columbia University 2004 / BA, Duke University 2001
Lawyer Rankings
United States > Finance > Restructuring (including bankruptcy): corporate
Goodwin advises borrowers, lenders, acquirers, and creditors’ committees in relation to a broad range of matters and has a particularly strong out-of-court restructuring offering in the healthcare, biotech, pharmaceuticals, and financial services sectors. Michael Goldstein in New York chairs the practice, with Howard Steel also a key name for Chapter 11 proceedings. Kizzy Jarashow was promoted to partner in October 2022 and stands out for her work in the biotech and pharmaceuticals spaces. Alexander Nicas joined the practice from Kirkland & Ellis LLP in April 2022.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)